p53 transactivation domain phosphorylation level is associated with poor clinicopathological features of wild-type p53 HCCs

被引：0
|
作者：
Kim, Hyeon-Seop [1 ]
Jung, Guhung [1 ]
机构：
[1] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：345 / 345
页数：1
相关论文
共 50 条
  • [31] Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
    Lee, M. K.
    Tong, W. M.
    Wang, Z. Q.
    Sabapathy, K.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (02): : 214 - 221
  • [32] Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
    M K Lee
    W M Tong
    Z Q Wang
    K Sabapathy
    Cell Death & Differentiation, 2011, 18 : 214 - 221
  • [33] WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO
    FARMER, G
    BARGONETTI, J
    ZHU, H
    FRIEDMAN, P
    PRYWES, R
    PRIVES, C
    NATURE, 1992, 358 (6381) : 83 - 86
  • [34] Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies
    Steels, Anneleen
    Verhelle, Adriaan
    Zwaenepoel, Olivier
    Gettemans, Jan
    MABS, 2018, 10 (07) : 1045 - 1059
  • [35] p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
    Jean-Christophe Bourdon
    Marie P Khoury
    Alexandra Diot
    Lee Baker
    Kenneth Fernandes
    Mustapha Aoubala
    Philip Quinlan
    Colin A Purdie
    Lee B Jordan
    Anne-Catherine Prats
    David P Lane
    Alastair M Thompson
    Breast Cancer Research, 13
  • [36] Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation
    Venkatachalam, S
    Shi, YP
    Jones, SN
    Vogel, H
    Bradley, A
    Pinkel, D
    Donehower, LA
    EMBO JOURNAL, 1998, 17 (16): : 4657 - 4667
  • [37] p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
    Bourdon, Jean-Christophe
    Khoury, Marie P.
    Diot, Alexandra
    Baker, Lee
    Fernandes, Kenneth
    Aoubala, Mustapha
    Quinlan, Philip
    Purdie, Colin A.
    Jordan, Lee B.
    Prats, Anne-Catherine
    Lane, David P.
    Thompson, Alastair M.
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [38] TRANSACTIVATION OF P53 THROUGH VARIOUS P53 RESPONSIVE ELEMENTS
    PARK, DJ
    CHUMAKOV, AM
    KOEFFLER, HP
    BLOOD, 1993, 82 (10) : A530 - A530
  • [39] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Wu, Jianyuan
    Li, Qingdi Quentin
    Zhou, Huiping
    Lu, Yinying
    Li, Jueli M.
    Ma, Yao
    Wang, Li
    Fu, Tingting
    Gong, Xingjiang
    Weintraub, Michael
    Wu, Shuangchan
    Ding, Hong
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [40] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101
12345